Home

  • About Ipnet
    • What is Ipnet ?
    • Statutes & bylaws
    • Membership application
    • Expert Clinical Center application
    • Ipnet Executive Board
    • General Assemblies
    • Ipnet Working Groups
    • Porphyria centres
    • Patient organizations
    • Corporate members
    • Honorary members
  • Patients
    • Introduction to porphyria
    • GPAC information statement
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria - diagnosis - FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
    • Patient organizations
    • Porphyria centres
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Webinars
    • Porphyria centres
  • Research
  • Contact

You are here

Home » About Ipnet » Corporate members

Corporate members

Agios Pharmaceuticals
Alnylam Switzerland GmbH
Clinuvel Pharmaceuticals LTD
Disc Medicine
Mitsubishi Tanabe Pharma Development America
Moderna Inc
Recordati Rare Diseases SARL

News

Key terms and definitions in acute porphyrias
Save the date - ICPP 2024 Pamplona
International Congress on Porphyrins and Porphyrias 2022
2022 Webinar Series : The Porphyrias - advanced diagnosing and management
2021 Webinar Series : The Porphyrias - introduction for non experts
Covid-19 vaccine safety

Search form

Home | Disclaimer
Copyright © 2023, International Porphyria Network.